Frequency News and Research

RSS

Study identifies risk factors linked with non-fatal overdose among HIV-infected Russians

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.

9 Jan 2014

New study finds that Americans had more health concerns during the recession

We ring in the New Year with hopes of being healthy, wealthy, and wise. A new study led by San Diego State University School of Public Health research professor John W. Ayers suggests that from a public health standpoint, health and wealth may be connected.

8 Jan 2014

Applied BioCode signs License and Supply Agreement with Genetic Analysis for BMB technology

Applied BioCode announced today that it has signed a License and Supply Agreement for its Barcoded Magnetic Bead technology with Genetic Analysis of Oslo, Norway.

7 Jan 2014

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

7 Jan 2014

Shield Therapeutics reports positive top-line data from pivotal Phase 3 programme of ST10

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces strongly positive top-line data from the pivotal Phase 3 programme of ST10 for the treatment of iron deficiency anaemia in inflammatory bowel disease.

7 Jan 2014

Second module of PMA application submitted to FDA for Sapheon's VenaSeal Sapheon Closure System

Sapheon Inc. announced today that it has submitted the second module of the pre-market approval application for the VenaSeal Sapheon Closure System to the U.S. Food and Drug Administration.

7 Jan 2014

Computer algorithm developed to identify genes that could be transformed to stop aging process

Restricting calorie consumption is one of the few proven ways to combat aging. Though the underlying mechanism is unknown, calorie restriction has been shown to prolong lifespan in yeast, worms, flies, monkeys, and, in some studies, humans.

2 Jan 2014

Women with high blood pressure need more optimal treatment than men

Doctors may need to treat high blood pressure in women earlier and more aggressively than they do in men, according to scientists at Wake Forest Baptist Medical Center.

2 Jan 2014

Cell phones, other distractions pose greater threat to teen drivers

Teens may begin their driving habits with great caution, but as months behind the wheel pass, they begin to multi-task at higher frequency rates - dialing cell phones, eating, and talking to passengers, etc. - and therefore greatly raise their risk of crashes and/or near-crash incidents.

2 Jan 2014

Research findings could shed light on how testosterone acts in human brain to regulate speech

For the male canary, the ability to sing a pitch-perfect song is critical to wooing female canaries. As the seasons change, so does song quality and frequency. The hormone testosterone plays a role in this changing song behavior.

31 Dec 2013

Electromed gets FDA clearance to market next generation SmartVest Airway Clearance System

Electromed, Inc., a global medical device company, today announced it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL has been cleared to market.

30 Dec 2013

Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients

C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke. Studies have report a higher C677T homozygosity frequency in Chinese than in Europeans. Usually, the detection of genetic diseases is rather complicated on a large scale owing to the invasive sampling and a cumbersome DNA extraction process.

27 Dec 2013

Researchers uncover new genetic clue that contributes to increased risk of type 2 diabetes

An international team of researchers in Mexico and the United States has uncovered a new genetic clue that contributes to an increased risk of developing type 2 diabetes, particularly the elevated risk among Mexican and other Latin American populations.

26 Dec 2013

Cognitive behavioral therapy reduces headache frequency, migraine-related disability in children

Among children and adolescents with chronic migraine, the use of cognitive behavioral therapy resulted in greater reductions in headache frequency and migraine-related disability compared with headache education, according to a study appearing in the December 25 issue of JAMA.

25 Dec 2013

Low testosterone levels linked to nocturia in men

Research from South Korea indicates that low testosterone levels are associated with nocturia in men, independent of both age and prostate volume.

24 Dec 2013

Acupuncture treatments may help alleviate side effects of breast cancer drugs

A new analysis has found that both real and sham acupuncture treatments may help alleviate side effects of drugs commonly used to treat breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help clinicians improve care for cancer patients. The results also raise the question of whether sham acupuncture is truly inert or may, like real acupuncture, have beneficial effects.

24 Dec 2013

Breast cancer patients experience fewer side effects on using aromatase inhibitor with sham acupuncture

Breast cancer patients experience fewer side effects while being treated with a widely used drug called an aromatase inhibitor when they get acupuncture - either the real treatment or a "sham" procedure, according to a new study led by researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center.

23 Dec 2013

Frequency News and Research

Study identifies risk factors linked with non-fatal overdose among HIV-infected Russians

New study finds that Americans had more health concerns during the recession

Applied BioCode signs License and Supply Agreement with Genetic Analysis for BMB technology

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

Shield Therapeutics reports positive top-line data from pivotal Phase 3 programme of ST10

Second module of PMA application submitted to FDA for Sapheon's VenaSeal Sapheon Closure System

Computer algorithm developed to identify genes that could be transformed to stop aging process

Women with high blood pressure need more optimal treatment than men

Cell phones, other distractions pose greater threat to teen drivers

Research findings could shed light on how testosterone acts in human brain to regulate speech

Electromed gets FDA clearance to market next generation SmartVest Airway Clearance System

Magnetic nanoparticles-based method uses saliva to screen DNA polymorphism in stroke patients

Researchers uncover new genetic clue that contributes to increased risk of type 2 diabetes

Cognitive behavioral therapy reduces headache frequency, migraine-related disability in children

Low testosterone levels linked to nocturia in men

Acupuncture treatments may help alleviate side effects of breast cancer drugs

Breast cancer patients experience fewer side effects on using aromatase inhibitor with sham acupuncture

Real and sham weekly acupuncture treatments ease hot flashes of anticancer drug treatment

Inflammatory burden increased in overweight bipolar disorder patients

Doctors should consider underlying inflammatory conditions when selecting anti-epilepsy drugs, say researchers

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News